Researcher Spotlight: Alexandra Rojek, MD the university of chicago Kristie Blum, MD Scholar Chimeric antigen receptor (CAR) T-cell therapy has improved outcomes for patients with B-cell lymphomas, but many patients still experience relapse after treatment. Dr. Rojek’s research has revealed…
Researcher Spotlight: Herman van Besien, MD weill cornell medicine Specialized immune cells from healthy donors who have previously been infected with Epstein-Barr virus (EBV) can be used to treat and kill cancer cells in patients with EBV-related lymphomas. Some subtypes…
Researcher Spotlight: Mengyang Di, MD, PhD University of Washington Runge Lymphoma Project Scholar Mosunetuzumab is a novel bispecific T cell engager used in the treatment of relapsed or refractory follicular lymphoma (FL). “Unfortunately, lymphoma still returns in most patients after…
Researcher Spotlight: Maria White, PhD The university of north carolina at chapel hill Epstein-Barr virus (EBV) is a common human pathogen that has been linked to the development of many types of cancers, including lymphoma. EBV-associated lymphomas are aggressive and…
Researcher Spotlight: Pierre Stéphan, MD, PhD brigham and women’s hospital Patients diagnosed with angioimmunoblastic T-cell lymphoma (AITL) face poor prognosis and limited treatment options. “We believe this is partly due to a lack of understanding of the complex set of…
Researcher Spotlight: Paurnima Patil, PhD memorial sloan kettering cancer center Oliver W. Press, MD, PhD, Memorial Fellow Dr. Patil’s research has identified a gene (ARHGEF2) that is multiplied in many cases of diffuse large B-cell lymphoma (DLBCL). The protein encoded…
Researcher Spotlight: Priya Lakra, PhD md anderson cancer center Health Equity Initiative Chromatin remodeling complexes known as BAF complexes are responsible for regulating gene expression and play important roles in the normal development of B cells. Expression of the different…
Researcher Spotlight: Daniela Magliulo, PhD weill cornell medicine Chromatin refers to DNA and protein complexes that form 3-dimensional structures within the genome. These structures can bring together genetic elements across long stretches of DNA or even between different chromosomes to…
Researcher Spotlight: Tianfang Ma, PhD Dana-farber cancer institute Health Equity Initiative Immunotherapies that activate the immune system against cancer cells have yielded promising results for many patients with diffuse large B-cell lymphoma (DLBCL), but not all people respond to treatment.…
Researcher Spotlight: Etienne Leveille, MD yale university Ferroptosis is a type of cell death to which therapy-resistant cancer cells have been found to be highly sensitive. Lymphomas, including diffuse large B-cell lymphoma (DLBCL), are among the most ferroptosis-sensitive types of…
